Sang‐Heon Lee

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados et al. · The Lancet · 2018 · 349 citations · Full text

Inflammation, Rheumatology, Rheumatoid Disorder +14

Size and Aggregation of Corticosteroids Used for Epidural Injections

Richard Derby, Sang‐Heon Lee, Elaine S. Date · Pain Medicine · 2007 · 217 citations · Full text

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

Atul Deodhar, Désirée van der Heijde, Lianne S. Gensler et al. · The Lancet · 2019 · 208 citations

Rheumatology, Spondyloarthritis, Rheumatic Diseases +8

Transient receptor potential V2 expressed in sensory neurons is activated by probenecid

Sangsu Bang, Kyung Yoon Kim, Sungjae Yoo et al. · Neuroscience Letters · 2007 · 148 citations

Neurophysiology, Sensory Neurons, Synaptic Transmission +11

Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposus

S. C. Lee, Chan Sam Moon, Donggeun Sul et al. · Clinical Biochemistry · 2009 · 127 citations

Degenerative Spine, Spinal Cord Injury, Intervertebral Disc +8